Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Are Biotech ETFs In Trouble As Coronavirus Dims Guidance?
Article By:
Zacks Investment Research
Saturday, May 9, 2020 7:49 PM EDT
Although the coronavirus seems to be opening up opportunities for biotech companies, it is dampening their guidance as well. Despite impressive results, most of these biotechs have been seeing declining share prices since the earnings releases.
E Portfolio Highlights: Movers And Shakers - March 2020
Article By:
Ingrid Hendershot
Thursday, March 12, 2020 3:32 AM EDT
During the past three months, the S&P 500 Index declined 5% due to fears of a recession brought on by the global impact of the coronavirus. Despite the overall market pullback, the following stocks generated gains during the same period.
Healthcare (Top 30 Weights) Earnings Estimates And Revisions
Article By:
T.J. Hayes
Monday, February 17, 2020 5:44 AM EDT
The cumulative 2020 earnings power of these 30 stocks was revised down by -.34% in the past 60 days.
In this article: EW, HCA, HUM, JNJ, LLY, MDT, MRK, PFE, SYK, TMO, UNH, ILMN, AMGN, BIIB, GILD, ISRG, VRTX Also: ABT, AGN, BAX, BDX, BMY, BSX, CI, CNC, CVS, DHR, XLV, ZTS, ABBV, ANTM
Alert: Alzheimer’s Drug Fails In Clinical Trial - Stocks Sink
What are the chances of $BIIB and $TSRO being bought out? They have long been targets, or at least rumored to be, for consolidation.